New Brunswick, New Jersey-based Johnson & Johnson (JNJ) engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. The company has a market cap of $640.8 billion and operates in two segments, Innovative Medicine and MedTech.
Shares of Johnson & Johnson have outperformed the broader market over the past year, surging 47.2% compared to the S&P 500 Index’s ($SPX) 10.5% surge. Moreover, in 2026, the stock has risen by nearly 32.9%, also outpacing the SPX’s 10.6% gain.